EXTRAFOLLICULAR B CELLS AND ANTI-SLIT DIAPHRAGM AUTOANTIBODIES UNDERLY A SHARED AUTOIMMUNE PATHOGENESIS IN CHILDHOOD AND ADULT IDIOPATHIC PODOCYTOPATHIES

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/5fd136dbcdbbcd2e7471ac09ae9b884c.pdf
EXTRAFOLLICULAR B CELLS AND ANTI-SLIT DIAPHRAGM AUTOANTIBODIES UNDERLY A SHARED AUTOIMMUNE PATHOGENESIS IN CHILDHOOD AND ADULT IDIOPATHIC PODOCYTOPATHIES

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Simon
Leclerc
Simon Leclerc simon.leclerc2@mail.mcgill.ca Research Institute of the McGill University Health Centre Department of Medicine, Division of Nephrology Montreal Canada *
Tho-Alfakar Al-Aubodah tho-alfakar.al-aubodah@mail.mcgill.ca Research Institute of the McGill University Health Centre Infectious Diseases and Immunity in Global Health Program Montreal Canada -
Lamine Aoudjit lamine.aoudjit@mcgill.ca Research Institute of the McGill University Health Centre Department of Medicine, Division of Nephrology Montreal Canada -
Ratna Samanta ratna.samanta@mcgill.ca Research Institute of the McGill University Health Centre Department of Medicine, Division of Nephrology Montreal Canada -
Cherry Mammen cmammen@cw.bc.ca University of British Columbia Department of Pediatrics, Division of Nephrology Vancouver Canada -
Allison Dart adart@hsc.mb.ca University of Manitoba Department of Pediatrics, Division of Nephrology Winnipeg Canada -
Anne-Laure Lapeyraque anne-laure.lapeyraque.med@ssss.gouv.qc.ca University of Montreal Department of Pediatrics, Division of Nephrology Montreal Canada -
Catherine Morgan cmorgan@ualberta.ca University of Alberta Department of Pediatrics, Division of Nephrology Edmonton Canada -
Mallory L. Downie mallory.downie@mcgill.ca Research Institute of the McGill University Health Centre Department of Pediatrics, Division of Nephrology Montreal Canada -
Kunimasa Yan yan-kunimasa@ks.kyorin-u.ac.jp Kyorin University School of Medicine Department of Pediatrics, Division of Nephrology Tokyo Japan -
Satoka Mori satoka-mori@denka.co.jp Denka Co., Ltd Diagnostics Research Department, Life Innovation Tokyo Japan -
Susan Samuel susan.samuel@ubc.ca University of British Columbia Department of Pediatrics, Division of Nephrology Vancouver Canada -
Ciriaco A. Piccirillo ciro.piccirillo@mcgill.ca Research Institute of the McGill University Health Centre Infectious Diseases and Immunity in Global Health Program Montreal Canada -
Tomoko Takano tomoko.takano@mcgill.ca Research Institute of the McGill University Health Centre Division of Nephrology Montreal Canada -
 

Idiopathic podocytopathies, namely idiopathic nephrotic syndrome in non-biopsied children and the histological diagnosis of minimal change disease and primary focal segmental glomerulosclerosis, are characterized by severe cytoskeletal derangements in podocytes that lead to nephrotic syndrome. These entities were long seen as a disease spectrum mediated by circulating factors, but the exact mechanisms causing podocyte injury remained elusive. Recently, the discovery of autoantibodies against slit diaphragm proteins in patients, along with the demonstration of nephrotic syndrome induction in mice by immunization with slit diaphragm proteins Nephrin and CRB2, strongly suggested an etiology of anti-slit diaphragm autoimmunity. However, the exact autoantibody landscape in idiopathic podocytopathies, including the presence of anti-CRB2 autoantibodies, and the immune dysregulations responsible for autoantibody production remain misunderstood. Our study aimed to examine the relationship between anti-slit diaphragm autoantibodies and B cell dysregulation in children and adults with idiopathic podocytopathies.

Anti-CRB2 and anti-Nephrin autoantibodies were measured by ELISA in a multicenter cohort of 82 patients with idiopathic podocytopathies, 22 with other glomerulopathies and 28 healthy controls. Kidney biopsy samples were stained for IgG deposits and imaged with confocal microscopy and high-resolution structured illumination microscopy. Peripheral blood B cell phenotype was assessed by flow cytometry. B cell transcriptional signatures and clonality were evaluated by single-cell RNA-sequencing.

Anti-CRB2 autoantibodies were detected in all types of active idiopathic podocytopathies, with seropositivity significantly higher in adults (27/31 [87%] vs 23/51 [45%], P < 0.01) and titers significantly reduced in remission (51 vs 115 µg/mL, P < 0.01). Double seropositivity for anti-CRB2 and anti-Nephrin was seen in 14/82 (17%) patients. IgG deposits colocalizing with CRB2 were identified in the glomeruli of anti-CRB2 seropositive patients. The expansion of extrafollicular T-bet+ CD21low atypical B cells, a population associated with autoimmunity, was seen in both children and adults. In children, both autoantibodies correlated with atypical B cell expansion. In adults, elevated frequencies of classical memory B cells indicated a greater degree of B cell dysregulation than in children. Further profiling in children using single-cell RNA-sequencing revealed a broadly dysregulated B cell pool poised for activation and the preferential accumulation of autoimmunity-prone VH4-39+ B cell clonotypes within the repertoire. 

We discovered that, despite being more frequent in adults, anti-CRB2 autoantibodies were seen in all types of idiopathic podocytopathies and could co-occur with anti-Nephrin autoantibodies. Moreover, we showed that children and adults had a dysregulated, autoimmunity prone B cell pool characterized by the expansion of extrafollicular atypical B cells. Altogether, these findings position anti-slit diaphragm autoimmunity as central to the pathogenesis of both childhood and adult idiopathic podocytopathies.

Kewords